Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy
暂无分享,去创建一个
D. Beyersdorff | Christian Wagner | M. Graefen | L. Budäus | T. Spieker | J. Witt | M. Kachanov | P. Rachubinski | J. Zinke | B. Fangmeyer | Sami-Ramzi Leyh-Bannurah | Andreas Schütte
[1] K. Rahbar,et al. Precision-guidance vs Systematic Sampling: Optimizing Biopsy Assessment of Secondary Prostate Cancer Suspicious Multiparametric Magnetic Resonance Imaging Lesions , 2022, The Journal of urology.
[2] Christian Wagner,et al. Feasibility of robot-assisted radical prostatectomy in men at senior age ≥75 years: perioperative, functional, and oncological outcomes of a high-volume center , 2021, The aging male : the official journal of the International Society for the Study of the Aging Male.
[3] M. Terris,et al. Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer , 2021, The Journal of urology.
[4] A. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. , 2021, European urology.
[5] S. Shariat,et al. Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer—A Systematic Review and Meta-Analysis , 2021, Cancers.
[6] A. Briganti,et al. Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review , 2021, World Journal of Urology.
[7] C. Iselin,et al. Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic , 2020, World Journal of Urology.
[8] Z. Savin,et al. The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings—Implications for the COVID-19 era , 2020, Urologic Oncology: Seminars and Original Investigations.
[9] A. George,et al. Delayed Radical Prostatectomy is Not Associated with Adverse Oncological Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic. , 2020, The Journal of urology.
[10] B. Trock,et al. Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study , 2020, European urology.
[11] A. Moinzadeh,et al. Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic , 2020, European Urology.
[12] P. Choyke,et al. MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. , 2020, The New England journal of medicine.
[13] K. Macura,et al. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. , 2020, European urology.
[14] M. Cooperberg,et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). , 2020, European urology.
[15] K. Trpkov,et al. The effect of time from biopsy to radical prostatectomy on adverse pathologic outcomes , 2019, Research and reports in urology.
[16] G. Muto,et al. A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy , 2019, World Journal of Urology.
[17] D. Nieboer,et al. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis. , 2020, European urology.
[18] S. Fosså,et al. Is time from diagnosis to radical prostatectomy associated with oncological outcomes? , 2018, World Journal of Urology.
[19] E. Faria,et al. Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter? , 2018, World Journal of Urology.
[20] F. Montorsi,et al. Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely? , 2017, Urologic oncology.
[21] A. Haese*,et al. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens. , 2016, European urology.
[22] P. Carroll,et al. Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. , 2015, European urology.
[23] K. Badani,et al. Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes , 2015, The Prostate.
[24] H. G. van der Poel,et al. Timing of curative treatment for prostate cancer: a systematic review. , 2013, European urology.
[25] M. Terris,et al. Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database , 2013, The Prostate.
[26] Jennifer R. Rider,et al. Natural history of early, localized prostate cancer: a final report from three decades of follow-up. , 2013, European urology.
[27] J. McKiernan,et al. Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis , 2012, BJU international.
[28] L. Holmberg,et al. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial. , 2009, European urology.